MolAI:用于数据驱动分子描述器生成和先进药物发现应用的深度学习框架.
Sayyed Jalil Mahdizadeh1, Leif A Eriksson1
1Department of Chemistry and Molecular Biology, University of Gothenburg, Göteborg 405 30, Sweden.
Journal of chemical information and modeling
|September 15, 2025
概括
一个深度学习模型MolaAI从2.21亿种化合物中生成分子描述符. 它的潜在空间表示能够准确预测分子性质,并增强药物发现过程.
科学领域:
- 计算化学是一种计算化学.
- 机器学习是机器学习.
- 药物发现 药物发现
背景情况:
- 分子描述器对于预测化学性质至关重要.
- 现有的描述符生成方法在范围和准确性方面可能受到限制.
- 深度学习为新型描述器生成提供了潜力.
研究的目的:
- 介绍MolAI,这是一个用于数据驱动分子描述器生成的深度学习模型.
- 在各种化学信息学应用中展示MolAI生成的描述符的实用性.
- 探索MolaAI在推动药物发现方面的潜力.
主要方法:
- 使用了2.21亿种独特化合物的大型数据集进行训练.
- 采用自编码器神经机器翻译模型来创建潜在空间表示.
- 通过分子再生精度 (>99.8%) 验证了模型的性能.
主要成果:
- 摩尔AI在从潜伏空间中再生分子方面取得了很高的准确性.
- 开发了一个基于ML的模型 (iLP) 用于使用MolaI描述器预测质子状态.
- 增强基于连接体的虚拟查和准确预测ADMET特征 (iADMET).
结论:
- MolAI提供了强大的,数据驱动的分子描述器.
- 由MolAI生成的描述符显著改善了化学和生物性质的预测建模.
- MolAI的编码/解码能力为药物发现和分子生成提供了新的途径.
更多相关视频
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.1K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
相关概念视频
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
